Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), Lead Poisoning Prevention (LPP) Subcommittee; Notice of Meeting, 6862 [2016-02574]
Download as PDF
<![CDATA[
6862
Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR), Lead Poisoning Prevention
(LPP) Subcommittee; Notice of
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC, National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry (NCEH/ATSDR)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 12:00 p.m.–1:45 p.m.,
EST, February 9, 2016.
Place: This meeting will be held by
teleconference. To participate in the
teleconference, please dial 1–877–315–
6535 Passcode: 383520.
Status: The meeting is open to the
public, limited only by the conference
lines available. The public is welcome
to participate during the public
comment period, which is tentatively
scheduled from 1:30 p.m. to 1:45 p.m.
This Federal Register Notice is being
published less than 15 days before the
meeting because of the urgent nature of
recent events involving the Flint,
Michigan water contamination with
lead. CDC is convening a meeting of the
Lead Subcommittee of the Board of
Scientific Counselors to initiate
discussion of public health measures
and assessments needed in response to
this event.
Purpose: The subcommittee will
propose strategies and options to the
Board of Scientific Counselors (BSC) on
ways to prioritize NCEH/ATSDR’s
activities, improve health outcomes, and
address health disparities as it relates to
lead exposures. The subcommittee will
deliberate on ways to evaluate lead
exposure and how to best conduct
health evaluations through exposure
and epidemiologic studies.
Subcommittee proposals on lead
prevention practices and national lead
poisoning prevention efforts will be
provided to the Board of Scientific
Counselors for deliberation and possible
adoption as formal recommendations to
NCEH/ATSDR.
Matters for Discussion: Agenda items
will include the following: Blood lead
testing and health surveillance strategies
for the residents of Flint, Michigan,
including methodological approaches
for conducting retrospective and
VerDate Sep<11>2014
17:54 Feb 08, 2016
Jkt 238001
prospective assessments of blood lead
levels and associated health outcomes.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
4770 Buford Highway, Mail Stop F–45,
Chamblee, Georgia 30345; telephone
770/488–0575, Fax: 770/488–3377;
Email: smalcom@cdc.gov.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing
(OMB Control No. 0920–0600, Expires
5/31/2016)—Extension—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–02574 Filed 2–4–16; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0600]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Background and Brief Description
As part of the continuing effort to
support domestic public health
objectives for treatment of tuberculosis
(TB), prevention of multi-drug
resistance, and surveillance programs,
CDC is requesting approval for an
extension of three years from the Office
of Management and Budget to continue
information collection from participants
in the Model Performance Evaluation
Program for Mycobacterium
Tuberculosis Susceptibility Testing.
Extension of this information collection
will not require changes in the scope of
the study, methodology, information
collection instruments, or burden on the
respondents.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium Tuberculosis Drug
Susceptibility Testing is used to monitor
and evaluate performance and practices
among national laboratories performing
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
Extension of this information
collection provides CDC with an
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 81, Number 26 (Tuesday, February 9, 2016)]
[Notices]
[Page 6862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02574]
[[Page 6862]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR), Lead Poisoning Prevention (LPP) Subcommittee; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC, National Center for
Environmental Health/Agency for Toxic Substances and Disease Registry
(NCEH/ATSDR) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 12:00 p.m.-1:45 p.m., EST, February 9, 2016.
Place: This meeting will be held by teleconference. To participate
in the teleconference, please dial 1-877-315-6535 Passcode: 383520.
Status: The meeting is open to the public, limited only by the
conference lines available. The public is welcome to participate during
the public comment period, which is tentatively scheduled from 1:30
p.m. to 1:45 p.m.
This Federal Register Notice is being published less than 15 days
before the meeting because of the urgent nature of recent events
involving the Flint, Michigan water contamination with lead. CDC is
convening a meeting of the Lead Subcommittee of the Board of Scientific
Counselors to initiate discussion of public health measures and
assessments needed in response to this event.
Purpose: The subcommittee will propose strategies and options to
the Board of Scientific Counselors (BSC) on ways to prioritize NCEH/
ATSDR's activities, improve health outcomes, and address health
disparities as it relates to lead exposures. The subcommittee will
deliberate on ways to evaluate lead exposure and how to best conduct
health evaluations through exposure and epidemiologic studies.
Subcommittee proposals on lead prevention practices and national lead
poisoning prevention efforts will be provided to the Board of
Scientific Counselors for deliberation and possible adoption as formal
recommendations to NCEH/ATSDR.
Matters for Discussion: Agenda items will include the following:
Blood lead testing and health surveillance strategies for the residents
of Flint, Michigan, including methodological approaches for conducting
retrospective and prospective assessments of blood lead levels and
associated health outcomes.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F-45,
Chamblee, Georgia 30345; telephone 770/488-0575, Fax: 770/488-3377;
Email: smalcom@cdc.gov.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-02574 Filed 2-4-16; 4:15 pm]
BILLING CODE 4163-18-P
